Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · IEX Real-Time Price · USD
2.680
+0.060 (2.29%)
At close: Mar 28, 2024, 4:00 PM
2.710
+0.030 (1.12%)
After-hours: Mar 28, 2024, 7:53 PM EDT

Esperion Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2011
Revenue
116.3375.4878.45227.55148.3600000
Upgrade
Revenue Growth (YoY)
54.14%-3.79%-65.52%53.37%------
Upgrade
Cost of Revenue
43.2726.9714.222.39000000
Upgrade
Gross Profit
73.0748.5164.23225.16148.3600000
Upgrade
Selling, General & Admin
142.52109.08184.99199.6265.8533.121.3818.2820.2410.92
Upgrade
Research & Development
86.11118.93105.98146.94175.61171.49147.657.8729.825.3
Upgrade
Operating Expenses
228.63228.01290.96346.55241.47204.59168.9876.1550.0436.22
Upgrade
Operating Income
-155.56-179.5-226.73-121.4-93.1-204.59-168.98-76.15-50.04-36.22
Upgrade
Interest Expense / Income
58.9856.8146.3522.678.120.030.200.520.27
Upgrade
Other Expense / Income
-5.29-2.65-3.98-0.52-4.06-2.8-2.19-1.17-0.78-0.12
Upgrade
Pretax Income
-209.25-233.66-269.11-143.55-97.17-201.81-166.99-74.98-49.78-36.38
Upgrade
Net Income
-209.25-233.66-269.11-143.55-97.17-201.81-166.99-74.98-49.78-36.38
Upgrade
Shares Outstanding (Basic)
103662927272724232216
Upgrade
Shares Outstanding (Diluted)
103662927272724232216
Upgrade
Shares Change
55.26%129.76%5.20%1.42%1.26%11.79%6.16%2.38%34.48%107.64%
Upgrade
EPS (Basic)
-2.03-3.52-9.31-5.23-3.59-7.54-6.98-3.33-2.26-2.22
Upgrade
EPS (Diluted)
-2.03-3.52-9.31-5.23-3.59-7.54-6.98-3.33-2.26-2.22
Upgrade
Free Cash Flow
-135.49-174.83-263.81-86.05-71.29-148.79-131.32-47.82-38.46-32.88
Upgrade
Free Cash Flow Per Share
-1.31-2.63-9.13-3.13-2.63-5.56-5.49-2.12-1.75-2.01
Upgrade
Gross Margin
62.81%64.27%81.88%98.95%100.00%-----
Upgrade
Operating Margin
-133.72%-237.83%-289.02%-53.35%-62.75%-----
Upgrade
Profit Margin
-179.87%-309.58%-343.04%-63.09%-65.49%-----
Upgrade
Free Cash Flow Margin
-116.46%-231.64%-336.29%-37.81%-48.05%-----
Upgrade
EBITDA
-150.11-176.35-222.14-120.33-88.73-201.52-166.53-74.73-49.03-35.95
Upgrade
EBITDA Margin
-129.03%-233.65%-283.18%-52.88%-59.80%-----
Upgrade
Depreciation & Amortization
0.160.50.610.550.320.270.260.250.240.16
Upgrade
EBIT
-150.27-176.85-222.76-120.88-89.05-201.78-166.79-74.98-49.26-36.11
Upgrade
EBIT Margin
-129.17%-234.31%-283.96%-53.12%-60.02%-----
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).